Elliott Waives BioMarin Board Deal, Moots Del. Suit

By Leslie A. Pappas · April 17, 2024, 2:39 PM EDT

Elliott Investment Management LP has waived an agreement with BioMarin Pharmaceutical Inc. that gave the activist investor three new seats on the biopharmaceutical company's board, mooting a Delaware Chancery Court lawsuit...

To view the full article, register now.